Profound Medical (PROF) Competitors $6.79 +0.04 (+0.59%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$6.79 0.00 (0.00%) As of 07:07 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PROF vs. CBLL, BFLY, RXST, AVNS, EMBC, DCTH, BVS, KIDS, AXGN, and NPCEShould you be buying Profound Medical stock or one of its competitors? The main competitors of Profound Medical include CeriBell (CBLL), Butterfly Network (BFLY), RxSight (RXST), Avanos Medical (AVNS), Embecta (EMBC), Delcath Systems (DCTH), Bioventus (BVS), OrthoPediatrics (KIDS), AxoGen (AXGN), and NeuroPace (NPCE). These companies are all part of the "medical equipment" industry. Profound Medical vs. Its Competitors CeriBell Butterfly Network RxSight Avanos Medical Embecta Delcath Systems Bioventus OrthoPediatrics AxoGen NeuroPace Profound Medical (NASDAQ:PROF) and CeriBell (NASDAQ:CBLL) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, dividends, community ranking, analyst recommendations, earnings and valuation. Does the MarketBeat Community believe in PROF or CBLL? Profound Medical received 31 more outperform votes than CeriBell when rated by MarketBeat users. However, 100.00% of users gave CeriBell an outperform vote while only 69.49% of users gave Profound Medical an outperform vote. CompanyUnderperformOutperformProfound MedicalOutperform Votes4169.49% Underperform Votes1830.51% CeriBellOutperform Votes10100.00% Underperform VotesNo Votes Which has preferable valuation and earnings, PROF or CBLL? CeriBell has higher revenue and earnings than Profound Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProfound Medical$11.86M17.20-$28.57M-$1.22-5.57CeriBell$71.54M8.97N/AN/AN/A Does the media prefer PROF or CBLL? In the previous week, CeriBell had 4 more articles in the media than Profound Medical. MarketBeat recorded 6 mentions for CeriBell and 2 mentions for Profound Medical. Profound Medical's average media sentiment score of 1.22 beat CeriBell's score of 1.20 indicating that Profound Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Profound Medical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CeriBell 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend PROF or CBLL? Profound Medical currently has a consensus price target of $11.50, suggesting a potential upside of 69.37%. CeriBell has a consensus price target of $32.50, suggesting a potential upside of 83.00%. Given CeriBell's higher possible upside, analysts clearly believe CeriBell is more favorable than Profound Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Profound Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00CeriBell 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders have more ownership in PROF or CBLL? 47.9% of Profound Medical shares are held by institutional investors. 1.5% of Profound Medical shares are held by insiders. Comparatively, 20.1% of CeriBell shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is PROF or CBLL more profitable? CeriBell has a net margin of 0.00% compared to Profound Medical's net margin of -349.41%. CeriBell's return on equity of 0.00% beat Profound Medical's return on equity.Company Net Margins Return on Equity Return on Assets Profound Medical-349.41% -85.22% -64.87% CeriBell N/A N/A N/A SummaryCeriBell beats Profound Medical on 9 of the 13 factors compared between the two stocks. Get Profound Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for PROF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PROF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PROF vs. The Competition Export to ExcelMetricProfound MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$204.06M$4.41B$5.57B$8.62BDividend YieldN/A42.67%5.28%4.18%P/E Ratio-5.0728.4427.1420.06Price / Sales17.2071.85419.32157.08Price / CashN/A51.0838.2534.64Price / Book5.305.917.064.70Net Income-$28.57M$67.63M$3.23B$247.88M7 Day Performance19.96%2.35%2.83%2.63%1 Month Performance58.64%17.24%9.02%6.36%1 Year Performance-25.63%19.59%31.36%14.05% Profound Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PROFProfound Medical2.5861 of 5 stars$6.79+0.6%$11.50+69.4%-24.0%$204.06M$11.86M-5.07150Positive NewsHigh Trading VolumeCBLLCeriBell2.7028 of 5 stars$17.81-0.4%$32.50+82.5%N/A$643.71M$71.54M0.00N/APositive NewsBFLYButterfly Network2.2843 of 5 stars$2.48flat$4.00+61.3%+169.6%$613.28M$85.63M-5.39460Positive NewsGap UpRXSTRxSight3.29 of 5 stars$15.30+1.7%$37.90+147.7%-74.1%$611.18M$148.31M-18.43220Positive NewsAVNSAvanos Medical1.7758 of 5 stars$12.63+1.4%N/A-37.4%$584.06M$689.20M37.154,040Positive NewsEMBCEmbecta4.288 of 5 stars$9.91+1.2%$19.33+95.1%-18.6%$579.17M$1.08B9.911,900DCTHDelcath Systems3.6341 of 5 stars$15.95-2.6%$24.00+50.5%+132.0%$555.48M$53.85M-11.8160BVSBioventus2.5668 of 5 stars$6.72+0.4%$14.33+113.3%+2.8%$552.01M$567.70M-11.021,200KIDSOrthoPediatrics4.3502 of 5 stars$21.54+1.7%$35.83+66.4%-25.8%$523.14M$212.45M-17.51200Positive NewsAXGNAxoGen2.3524 of 5 stars$10.41-4.7%$22.20+113.3%+37.8%$474.11M$194.52M-32.53450Positive NewsHigh Trading VolumeNPCENeuroPace3.7617 of 5 stars$12.93-1.7%$15.50+19.9%+85.4%$431.31M$84.31M-12.93170Analyst Revision Related Companies and Tools Related Companies CBLL Competitors BFLY Competitors RXST Competitors AVNS Competitors EMBC Competitors DCTH Competitors BVS Competitors KIDS Competitors AXGN Competitors NPCE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PROF) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored2025 Market Crash50-Year Legend: Here's The Day Stocks Likely Crash Investing legend finds best cycle indicator during 50-ye...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profound Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Profound Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PROF Stock Free PROF Stock Alerts